J&J Delivers No Evidence FDA Knew Of "Phantom" Recall - Congressional Staff
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson failed to provide proof that FDA acknowledged the firm's plan for a "phantom" recall of a Motrin product, according to Capitol Hill staff